Prophylactic antibiotics for postcataract surgery endophthalmitis: a systematic review and network meta-analysis of 6.8 million eyes

Sci Rep. 2022 Oct 18;12(1):17416. doi: 10.1038/s41598-022-21423-w.

Abstract

To reveal optimal antibiotic prophylactic regimen for postoperative endophthalmitis (POE), we conducted systematic review and network meta-analysis. A total of 51 eligible original articles, including two randomized controlled trials, were identified. In total, 4502 POE cases occurred in 6,809,732 eyes (0.066%). Intracameral injection of vancomycin had the best preventive effect (odds ratio [OR] 0.03, 99.6% confidence interval [CI] 0.00-0.53, corrected P-value = 0.006, P-score = 0.945) followed by intracameral injection of cefazoline (OR 0.09, 99.6% CI 0.02-0.42, corrected P-value < 0.001, P-score = 0.821), cefuroxime (OR 0.18, 99.6% CI 0.09-0.35, corrected P-value < 0.001, P-score = 0.660), and moxifloxacin (OR 0.36, 99.6% CI 0.16-0.79, corrected P-value = 0.003, P-score = 0.455). While one randomized controlled trial supported each of intracameral cefuroxime and moxifloxacin, no randomized controlled trial evaluated vancomycin and cefazoline. Sensitivity analysis focusing on the administration route revealed that only intracameral injection (OR 0.19, 99.4% CI 0.12-0.30, corrected P-value < 0.001, P-score = 0.726) significantly decreased the risk of postoperative endophthalmitis. In conclusion, intracameral injection of either vancomycin, cefazoline, cefuroxime, or moxifloxacin prevented POE.

Publication types

  • Meta-Analysis
  • Systematic Review

MeSH terms

  • Anterior Chamber
  • Anti-Bacterial Agents / therapeutic use
  • Antibiotic Prophylaxis
  • Cataract Extraction* / adverse effects
  • Cefuroxime / therapeutic use
  • Endophthalmitis* / drug therapy
  • Endophthalmitis* / etiology
  • Endophthalmitis* / prevention & control
  • Humans
  • Moxifloxacin / therapeutic use
  • Network Meta-Analysis
  • Postoperative Complications / drug therapy
  • Postoperative Complications / prevention & control
  • Vancomycin

Substances

  • Cefuroxime
  • Vancomycin
  • Moxifloxacin
  • Anti-Bacterial Agents